Ralf Reilmann1, Mark Forrest Gordon2, Robin Schubert1, Karen E. Anderson3, Andrew Feigin4, Sarah J. Tabrizi5, Blair R. Leavitt6,
![Teva Men's Original Universal Sandal, Grey Multi, 12 : Buy Online at Best Price in KSA - Souq is now Amazon.sa: Fashion Teva Men's Original Universal Sandal, Grey Multi, 12 : Buy Online at Best Price in KSA - Souq is now Amazon.sa: Fashion](https://m.media-amazon.com/images/I/41sg0CtMXnL._AC_.jpg)
Teva Men's Original Universal Sandal, Grey Multi, 12 : Buy Online at Best Price in KSA - Souq is now Amazon.sa: Fashion
![Teva Men's Original Universal Sandal, Grey Multi, 12 : Buy Online at Best Price in KSA - Souq is now Amazon.sa: Fashion Teva Men's Original Universal Sandal, Grey Multi, 12 : Buy Online at Best Price in KSA - Souq is now Amazon.sa: Fashion](https://m.media-amazon.com/images/I/51dpvIZRJSL._AC_.jpg)
Teva Men's Original Universal Sandal, Grey Multi, 12 : Buy Online at Best Price in KSA - Souq is now Amazon.sa: Fashion
![Safety and efficacy of laquinimod for Huntington's disease (LEGATO-HD): a multicentre, randomised, double-blind, placebo-controlled, phase 2 study - ScienceDirect Safety and efficacy of laquinimod for Huntington's disease (LEGATO-HD): a multicentre, randomised, double-blind, placebo-controlled, phase 2 study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1474442223004544-gr3.jpg)
Safety and efficacy of laquinimod for Huntington's disease (LEGATO-HD): a multicentre, randomised, double-blind, placebo-controlled, phase 2 study - ScienceDirect
![Disappointing news from LEGATO-HD trial of laquinimod in Huntington's disease - HDBuzz - Huntington's disease research news. Disappointing news from LEGATO-HD trial of laquinimod in Huntington's disease - HDBuzz - Huntington's disease research news.](https://en.hdbuzz.net/system/production/media/picture/622/redesign3point0_codev-2018-07-31-6e726deced-LEGATOHDlogoRGB.jpg)
Disappointing news from LEGATO-HD trial of laquinimod in Huntington's disease - HDBuzz - Huntington's disease research news.
![Safety and efficacy of laquinimod for Huntington's disease (LEGATO-HD): a multicentre, randomised, double-blind, placebo-controlled, phase 2 study - The Lancet Neurology Safety and efficacy of laquinimod for Huntington's disease (LEGATO-HD): a multicentre, randomised, double-blind, placebo-controlled, phase 2 study - The Lancet Neurology](https://www.thelancet.com/cms/asset/6d9e7d43-507a-40bf-b41f-000a180c8d2e/gr1.jpg)